SimpliFASD

Q: What language does SimpliFASD support?

SimpliFASD supports English,Catalan,Dutch,French,German,Italian,Persian,Slovenian,Spanish,Thai,Urdu,Vietnamese,Zulu

Free

807for iPhone, iPad and more

Avicenna Research Inc.

Developer

185.4 MB

Size

Mar 13, 2024

Update Date

Health & Fitness

Category

Age Rating

App Store Developer Website

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

SimpliFASD Screenshots

iPad

iPhone

About SimpliFASD

With the decision tree, prescribers will be able to identify one of four clusters of symptoms with which to target treatment. "Clusters" include hyperarousal, emotional dysregulation, hyperactivity/neurocognitive, and cognitive inflexibility. Once the primary cluster with the greatest impact on patient functioning is known, then the algorithm decision tree identifies a first-line and second-line medication to prescribe. An adjunct therapy is also given for each cluster. Using the decision tree will help manage FASD/ND-PAE patients improve daily function and reduce unnecessary and unwanted medication. Four to six weeks after using the decision tree, prescribers can complete a brief survey to help evaluate the effectiveness of this first-ever medication decision tree for FASD/ND-PAE patients.

** This app integrates with the Health app **